Clearside Biomedical Inc

NASDAQ:CLSD   3:59:51 PM EDT
6.39
-0.45 (-6.58%)
Products, Strategic Combinations

Clearside Biomedical Expands Xipere License Agreement With Arctic Vision To Include Australia, New Zealand, India And Asean Countries

Published: 09/09/2021 11:34 GMT
Clearside Biomedical Inc (CLSD) - Clearside Biomedical Expands Xipere™ License Agreement With Arctic Vision to Include Australia, New Zealand, India and Asean Countries.
Clearside Biomedical - Under Terms of Amended Agreement, Will Receive a Total of $3.0 Million in Upfront Payments.
Clearside Biomedical-under Terms of Amended Agreement, Entitled to Additional Payments Upon Achievement of Certain Milestones in Newly Added Countries.
Clearside Biomedical - Entitled to Receive Tiered Royalties of 10% to 12% Based on Annual Net Sales of Arvn001 in Territories Under Amended Agreement.